Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
Open Access
- 23 July 2020
- journal article
- research article
- Published by Wiley in The FEBS Journal
- Vol. 287 (17), 3693-3702
- https://doi.org/10.1111/febs.15495
Abstract
Aim To evaluate associations of plasma 25(OH)D status with the likelihood of coronavirus disease (COVID‐19) infection and hospitalization. Methods The study population included the 14,000 members of Leumit Health Services who were tested for COVID‐19 infection from February 1st to April 30th 2020, and who had at least one previous blood test for plasma 25(OH)D level. "Suboptimal" or "low" plasma 25(OH)D level was defined as plasma 25‐hydroxyvitamin D, or 25(OH)D, concentration below the level of 30 ng/mL. Results Of 7,807 individuals, 782 (10.1%) were COVID‐19‐positive, and 7,025 (89.9%) COVID‐19‐negative. The mean plasma vitamin D level was significantly lower among those who tested positive than negative for COVID‐19 [19.00 ng/mL (95% confidence interval [CI] 18.41‐19.59) vs . 20.55 (95% CI 20.32‐20.78)]. Univariate analysis demonstrated an association between low plasma 25(OH)D level and increased likelihood of COVID‐19 infection [crude odds ratio (OR) of 1.58 (95% CI 1.24‐2.01, p<0.001)], and of hospitalization due to the SARS‐CoV‐2 virus [crude OR of 2.09 (95% CI 1.01‐ 4.30, p<0.05)]. In multivariate analyses that controlled for demographic variables, and psychiatric and somatic disorders, the adjusted OR of COVID‐19 infection [1.45 (95% CI 1.08‐1.95, p<0.001)], and of hospitalization due to the SARS‐CoV‐2 virus [1.95 (95% CI 0.98‐4.845, p=0.061)] were preserved. In the multivariate analyses, age over 50 years, male gender and low‐medium socioeconomic status were also positively associated with the risk of COVID‐19 infection; age over 50 years was positively associated with the likelihood of hospitalization due to COVID‐19. Conclusion Low plasma 25(OH)D level appears to be an independent risk factor for COVID‐19 infection and hospitalization.Keywords
This publication has 61 references indexed in Scilit:
- Evaluation of the novel DiaSorin LIAISON ® Campylobacter assay for the rapid detection of Campylobacter spp.Enfermedades Infecciosas y Microbiología Clínica, 2018
- The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and preventionReviews in Endocrine and Metabolic Disorders, 2017
- Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant dataBMJ, 2017
- Blood levels of vitamin D and health‐functional status in asymptomatic individuals: a cross sectional studyJournal of Evaluation in Clinical Practice, 2016
- Seasonal vitamin D changes and the impact on health risk assessmentClinical Biochemistry, 2014
- The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organizationInternational Journal of Cardiology, 2011
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2011
- Vitamin D status of county hospital patients assessed by the DiaSorin LIAISON® 25-hydroxyvitamin D assayClinica Chimica Acta; International Journal of Clinical Chemistry, 2011
- Vitamin D and Risk of Cognitive Decline in Elderly PersonsJAMA Internal Medicine, 2010
- What is the optimal vitamin D status for health?Progress in Biophysics and Molecular Biology, 2006